MiMedx Group (NASDAQ:MDXG – Get Free Report) was upgraded by research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Monday. Other equities research analysts have also issued research reports about the stock. Lake Street Capital initiated coverage on shares of MiMedx Group in a research […]
Shares of MiMedx Group, Inc. (NASDAQ:MDXG – Get Free Report) have been given an average recommendation of “Buy” by the four research firms that are presently covering the stock, Marketbeat reports. Four analysts have rated the stock with a buy rating. The average 12-month target price among brokerages that have updated their coverage on the […]
Femasys (NASDAQ:FEMY – Get Free Report) and MiMedx Group (NASDAQ:MDXG – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, earnings, risk, profitability and valuation. Risk and Volatility Femasys has a beta of […]
Hillsdale Investment Management Inc. increased its stake in shares of MiMedx Group, Inc. (NASDAQ:MDXG – Free Report) by 69.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 447,900 shares of the company’s stock after buying an additional 183,141 shares during the […]
Richmond Brothers Inc. decreased its position in shares of MiMedx Group, Inc. (NASDAQ:MDXG – Free Report) by 5.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,404,352 shares of the company’s stock after selling 76,980 shares during the quarter. MiMedx Group accounts […]